Zeynep Elmas
Ulm, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Multiplex Panel Detects Glial and Inflammatory Biomarker Signatures in Sporadic and C9orf72-ALS.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 16, 2026
Blood SOD1 Activity in ALS Patients Receiving Tofersen Treatment.
Journal: Annals of neurology
Published: April 22, 2026
Distinct cerebrospinal fluid profiles of astrocytic aquaporin-4 and GFAP in neuroinflammatory disorders.
Journal: Neurobiology of disease
Published: January 12, 2026
Evaluating the short-term and long-term therapeutic effects of immunoadsorption compared with plasma exchange in chronic inflammatory demyelinating polyneuropathy: a long-term, prospective, observational study.
Journal: EClinicalMedicine
Published: September 18, 2025
Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseases.
Journal: Journal of neurology
Published: June 01, 2025
Extracorporeal therapy procedures (plasma exchange and immunoadsorption) in chronic inflammatory demyelinating polyneuropathies (CIDP)- a database analysis.
Journal: BMC neurology
Published: March 24, 2025
CSF levels of the somatodendritic protein MAP2 are increased in ALS and predict shorter survival.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: March 10, 2025
Correction: Clinical characterization of common pathogenic variants of SOD1-ALS in Germany.
Journal: Journal of neurology
Published: March 08, 2025
Alterations of Fat and Ketone Body Metabolism in ALS and SMA-A Prospective Observational Study.
Journal: European journal of neurology
Published: December 29, 2024
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis.
Journal: Annals of neurology
Published: December 16, 2024
Last Updated: 09/26/2026